Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-03-000002
Filing Date
2003-09-26
Accepted
2003-09-26 16:38:50
Documents
1
Period of Report
2003-09-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5169
  Complete submission text file 0000891293-03-000002.txt   6937
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address DISCOVERY LABORATORIES INC 509 MADISON AVE 14TH FLOOR NEW YORK NY 10022 2122234504
LINK MAX (Reporting) CIK: 0001050944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 03912899